Tag: Disease-modifying antirheumatic drugs

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Disease-modifying antirheumatic drugs

EC Grants Marketing Authorization to Celltrion Biosimilar for Arthritis Treatment

Added to Collection on: 2025-02-26 16:30:54

Tags for this article:

Monoclonal antibodies
Orphan drugs
Specialty drugs
Immunosuppressants
Disease-modifying antirheumatic drugs
Celltrion
Tocilizumab
Regdanvimab
Bevacizumab
Biosimilar
Genentech
Biopharmaceutical

Click the tags to see associated articles and topics

View Article Details
Bioengineered Protein Drugs Market: Surging from US$347.1 Bn in 2023 to US$672.7 Bn by 2034

Added to Collection on: 2025-03-03 15:29:53

Tags for this article:

Pharmacy
Biotechnology
Biotechnology products
Biopharmaceuticals
Disease-modifying antirheumatic drugs
Biosimilar
BioMarin Pharmaceutical
Adalimumab
Amgen
Pharmaceutical industry
Autoimmune disease
Chronic condition

Click the tags to see associated articles and topics

View Article Details
Bioengineered Protein Drugs Market Size to Cross USD 672.7 - GlobeNewswire

Added to Collection on: 2025-03-13 22:07:55

Tags for this article:

Pharmacy
Disease-modifying antirheumatic drugs
Immunosuppressants
TNF inhibitors
Biotechnology
Biopharmaceutical
Biosimilar
Biocon
Pharmaceutical industry
Etanercept
Adalimumab
Amgen
United States
Wilmington

Click the tags to see associated articles and topics

View Article Details
TNF Inhibitors vs Non-TNF DMARDs in Rheumatoid Arthritis-Associated Lung Disease

Added to Collection on: 2025-03-24 08:36:24

Tags for this article:

Rheumatology
Disease-modifying antirheumatic drugs
Immunosuppressants
Monoclonal antibodies
Arthritis
TNF inhibitor
Rheumatoid arthritis
Etanercept
Interstitial lung disease
Tumor necrosis factor
Rheumatoid lung disease
Methotrexate

Click the tags to see associated articles and topics

View Article Details
Amgen CEO Bob Bradway's 2024 Letter to Shareholders

Added to Collection on: 2025-04-02 17:04:01

Tags for this article:

Orphan drugs
Monoclonal antibodies
Disease-modifying antirheumatic drugs
Amgen
Pharmaceutical companies
Adalimumab
Apremilast
Horizon Therapeutics
Blinatumomab
Denosumab
Trastuzumab
Obesity
Amgen Singapore Manufacturing

Click the tags to see associated articles and topics

View Article Details
The Top 5 Biosimilar Articles for the Week of March 31

Added to Collection on: 2025-04-04 11:08:21

Tags for this article:

Monoclonal antibodies
Immunosuppressants
Biopharmaceuticals
Biosimilar
TNF inhibitors
Disease-modifying antirheumatic drugs
Denosumab
Adalimumab
Natalizumab
Biogen

Click the tags to see associated articles and topics

View Article Details
Topline Results from Phase IIIb APEX Trial Shows Efficacy of Tremfya for Active Psoriatic Arthritis

Added to Collection on: 2025-04-07 17:43:18

Tags for this article:

Rheumatology
Autoimmune diseases
Psoriasis
Arthritis
Disease-modifying antirheumatic drugs
Guselkumab
Psoriatic arthritis
Apremilast
Ixekizumab
, Johnson &Johnson
Johnson & Johnson

Click the tags to see associated articles and topics

View Article Details
AbbVie's Rinvoq Gets EU Nod for 8th Indication Giant Cell Arteritis - TradingView

Added to Collection on: 2025-04-08 14:56:50

Tags for this article:

Autoimmune diseases
Rheumatology
Arthritis
Disease-modifying antirheumatic drugs
Anti-inflammatory agents
Janus kinase inhibitor
Psoriatic arthritis
Tofacitinib
Upadacitinib
AbbVie
Alopecia areata
Baricitinib
ABBVIE’S

Click the tags to see associated articles and topics

View Article Details
Biopharmaceutical Market Size & Share Report, 2025 - 2034

Added to Collection on: 2025-04-11 09:23:54

Tags for this article:

Biotechnology
Pharmaceutical industry
Disease-modifying antirheumatic drugs
Immunosuppressants
Biopharmaceutical
Biosimilar
Pharmaceutical industry in India
Novartis
Eli Lilly and Company
AbbVie
AstraZeneca
Biogen
Erythropoietin

Click the tags to see associated articles and topics

View Article Details
Biologic & Biosimilar RA Drugs Market Forecast 2025-2034: - openPR.com

Added to Collection on: 2025-04-18 08:16:13

Tags for this article:

Disease-modifying antirheumatic drugs
Immunosuppressants
Biopharmaceuticals
TNF inhibitors
Biotechnology
Biosimilar
Adalimumab
Biocon
Sandoz
Samsung Biologics
Gedeon Richter
Novartis
Business Research Company

Click the tags to see associated articles and topics

View Article Details
Book a Demo
OSZAR »